April 27, 2022
Initiative Overview: IGR – QTL
Explore
PPTX
April 27, 2022
Initiative Overview – Diversity of Participants in Clinical Trials
Provides an overview of the Diversity of Participants in Clinical Trials initiative and its available solutions.
Explore
February 14, 2022
Initiative Overview – Privacy Methodology for Data Sharing
This overview provides the background of the Privacy Methodology for Data Sharing initiative which is seeking to assist identify a model approach to implementing privacy safeguards that will provide increased transparency and enable simpler utilization of clinical trial data re-use.
Explore
October 5, 2021
PT Value Flashcard – Vendor and Sponsors Engagement Considerations
An introductory document about the Vendor and Sponsors Engagement Considerations with a brief description of the deliverable, target stakeholders, call to action and value/benefits.
Explore
October 5, 2021
PT Value Flashcard – PTSFQ
An introductory document about the PTSFQ with a brief description of the deliverable, target stakeholders, call to action and value/benefits.
Explore
October 5, 2021
PT Value Flashcard – PT Implementation Framework
An introductory document about the PT Implementation Framework with a brief description of the deliverable, target stakeholders, call to action and value/benefits.
Explore
October 5, 2021
PT Value Flashcard – PT Discussion Guide
An introductory document about the PT Discussion Guide with a brief description of the deliverable, target stakeholders, call to action and value/benefits.
Explore
October 5, 2021
PT Value Flashcard – Patient Considerations
An introductory document about the Patient Considerations with a brief description of the deliverable, target stakeholders, call to action and value/benefits.
Explore
April 13, 2021
Initiative Overview- Value of Safety Information Data Sources
Provides an overview of the workstream, and work accomplished to date.
Explore
April 13, 2021
Initiative Overview -Real World Data
Provides a brief overview of the Real World Data initiative which aims to collaborate with global regulatory agencies to develop a framework for RWD that defines tools, methodologies, use cases, and appropriate levels of evidence to support regulatory decision-making.
Explore